Quantifying the Rate of Ellipsoid Zone Loss in Stargardt Disease

被引:31
|
作者
Cai, Cindy X. [1 ]
Light, Jacob G. [1 ]
Handa, James T. [1 ]
机构
[1] Johns Hopkins Univ Hosp, Wilmer Eye Inst, Baltimore, MD 21287 USA
关键词
OPTICAL COHERENCE TOMOGRAPHY; SHORT-WAVELENGTH AUTOFLUORESCENCE; LINKED RETINITIS-PIGMENTOSA; ABC TRANSPORTER ABCA4; FUNDUS FLAVIMACULATUS; VISUAL-ACUITY; GENE-THERAPY; PROGRESSION; ATROPHY; PHOTORECEPTORS;
D O I
10.1016/j.ajo.2017.10.032
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To determine a reliable method of using the ellipsoid zone (EZ) on optical coherence tomography (OCT) to track disease progression in Stardgardt disease (STGD). DESIGN: Retrospective reliability study. METHODS: STGD patients with genetically confirmed ABCA4 gene mutations seen at the Wilmer Eye Institute with follow-up visits separated by at least 12 months were identified. Spectral-domain optical coherence tomography (SD-OCT) macula volume scans centered at the fovea and fundus autofluorescence (FAF) images were obtained. The area of EZ loss was calculated from the SD-OCT and the area of retinal pigment epithelium (RPE) loss from the FAF. Scans were reanalyzed by the primary grader to assess intragrader reliability, and reanalyzed by a second grader to assess intergrader reliability. RESULTS: Sixteen STGD patients (total of 31 eyes) were followed for a mean of 2 years (range 1-4.7 years). The mean rate of EZ loss, 0.31 +/- 0.31 mm(2)/year, was similar to the average rate of RPE loss, 0.33 +/- 0.38 mm(2)/year. The average area of EZ loss at the initial examination, 4.18 +/- 1.91 mm(2), was larger than the initial area of RPE loss, 2.25 +/- 1.66 mm(2) (P < .01). The absolute difference of the area of EZ loss on test-retest for the first grader was 0.12 0.10 mm(2), and between graders 0.21 +/- 0.21 mm(2). The intraclass correlation (ICC) of both intragrader and intergrader reliability for EZ loss was excellent at 0.99. CONCLUSIONS: Tracking the area of EZ loss on SD-OCT macular volume scans longitudinally is a reliable way of monitoring disease progression in STGD. This could be used as a sensitive anatomic outcome measure in clinical trials related to STGD. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [41] Colour Vision in Stargardt Disease
    Vandenbroucke, Tine
    Buyl, Ronald
    De Zaeytijd, Julie
    Bauwens, Miriam
    Uvijls, Andre
    De Baere, Elfride
    Leroy, Bart P.
    OPHTHALMIC RESEARCH, 2015, 54 (04) : 181 - 194
  • [42] The Rate of Progressive Loss of Central Subfield Thickness (CSFT) and Visual Function in Stargardt Macular Dystrophy (STGD)
    Galles, Daniel
    Birch, David G.
    Wang, Yi-Zhong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [43] Ellipsoid zone on optical coherence tomography: a review
    Tao, Lingwei William
    Wu, Zhichao
    Guymer, Robyn H.
    Luu, Chi D.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 44 (05): : 422 - 430
  • [44] STARGARDT DISEASE AND FUNDUS FLAVIMACULATUS
    AJAMIAN, PC
    WALLACE, W
    JOURNAL OF THE AMERICAN OPTOMETRIC ASSOCIATION, 1982, 53 (12) : 1005 - 1006
  • [45] Novel therapeutics for Stargardt disease
    Lu, Louise J.
    Liu, Ji
    Adelman, Ron A.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (06) : 1057 - 1062
  • [46] A new model for Stargardt disease?
    Alexandra Le Bras
    Lab Animal, 2019, 48 : 138 - 138
  • [47] Therapy Approaches for Stargardt Disease
    Piotter, Elena
    McClements, Michelle E.
    MacLaren, Robert E.
    BIOMOLECULES, 2021, 11 (08)
  • [48] Gene therapy for Stargardt disease
    Audo, I.
    Mohand-Said, S.
    Zeitz, C.
    Barale, P. O.
    Sahel, J-A
    ACTA OPHTHALMOLOGICA, 2014, 92
  • [49] Stargardt Disease in Young Patients
    Peterson, Bridget
    Akula, James D.
    Mihalek, Ivana
    Hansen, Ronald M.
    Fulton, Anne B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [50] Novel therapeutics for Stargardt disease
    Louise J. Lu
    Ji Liu
    Ron A. Adelman
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 1057 - 1062